Condition
Palatability
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07421466Not ApplicableCompleted
Umami Taste Intensity and Meal Intake
NCT07199543Phase 1Completed
Palatability Study of Five Formulations of Benzydamine HCl Lozenges
NCT07059117Not ApplicableCompleted
Umami Taste Intensity and ad Libitum Meal Intake
NCT02233959CompletedPrimary
Palatability of a Novel Oral Formulation of Prednsione
Showing all 4 trials